000 02123cam a2200349 a 4500
003 EG-GiCUC
005 20250223030943.0
008 140317s2013 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.08.09.M.Sc.2013.Sa.P
100 0 _aSara Abdelmgeed Hamed Elwakeel
245 1 0 _aPossible modulation of inflammator mediatiors and hepatic fibrosis by an angiotensin II receptor blocker (ARB) in a rat model of CC14-induced liver injury /
_cSara Abdelmgeed Hamed Elwakeel ; Supervised Ezz Eldin S. Eldenshary , Moushira Ibrahim Elsayed , Noha N. Nassar
246 1 5 _aالتغيرات التى يمكن حدوثها للوسطاء الالتهابية والتليف الكبدى باستخدام مثبطات مستقبلات الانجيوتنسين 2 فى نموذج للجرذان المصابة بتليف كبدى ناجم عن استخدام رابع كلوريد الكربون
260 _aCairo :
_bSara Abdelmgeed Hamed Elwakeel ,
_c2013
300 _a90 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
520 _aHepatic fibrosis is defined as a wound healing response to liver injury characterized by the deposition of extracellular matrix (ECM). The duration of insult is a crucial parameter managing the extent of injury. Whereas an acute insult provokes transient changes and the normal hepatic architecture is regenerated, a more persistent injury results in sustained chronic inflammation and accumulation of ECM leading to progressive substitution of liver parenchyma by scar tissue
530 _aIssued also as CD
653 4 _aAngiotensin II
653 4 _aHepatic fibrosis
653 4 _aLiver injury
700 0 _aEzz Eldin S. Eldenshary ,
_eSupervisor
700 0 _aMoushira Ibrahim Elsayed ,
_eSupervisor
700 0 _aNoha N. Nassar ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAml
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c45419
_d45419